Related Experiment Videos
Antisense peptide nucleic acids in antibacterial drug discovery
1GlaxoSmithKline Research and Development, Collegeville, PA, USA.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|September 29, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Broad-Spectrum Antibacterial Activity of Antioxidant Octyl Gallate and Its Impact on Gut Microbiome.
Antibiotics (Basel, Switzerland)·2024
New Insights into the Biological Functions of Essential TsaB/YeaZ Protein in Staphylococcus aureus.
Antibiotics (Basel, Switzerland)·2024
Antibacterial effect of rose bengal against colistin-resistant gram-negative bacteria.
The Journal of antibiotics·2023
Advanced iPSC-based modelling of LMNA-related congenital muscular dystrophy enables development of genetic therapies for muscle laminopathies.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Antisense oligonucleotides against Il6ra ameliorate cancer cachexia in mice.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Leveraging host cell modulators of adeno-associated vectors transduction to tailor viral biodistribution.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Pan-Cancer Oncolytic Virotherapy Through Disruption of Tumor Cell Mitochondrial Dynamics.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A complement C5-targeted GalNAc-conjugated siRNA with sustained efficacy in a non-human primate model of IgA nephropathy.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.
Archiv der Pharmazie·2026
Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.
ACS medicinal chemistry letters·2026
Novel Heterocyclic Compounds for Treating HIV Infection.
ACS medicinal chemistry letters·2026
Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.
ACS medicinal chemistry letters·2026